id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ffhd-43	Mikirova, N. A.; Casciari, J. J.; Hunninghake, R. E.; Riordan, N. H.	Intravenous ascorbic acid protocol for cancer patients: scientific rationale, pharmacology, and clinical experience	2013		.htm	text/html	574	17	25	Intravenous ascorbic acid protocol for cancer patients: scientific rationale, pharmacology, and clinical experience | Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Skip to main content Skip to main navigation menu Skip to site footer Open Menu Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Home Food Science Publisher Functional Food Center Current Archives About About the Journal Aims and Scope Contact Editing Services Editorial Team Express Peer Review Graphical Abstract Journal Insights Privacy Statement Submissions Announcements Search Search Register Login Home / Archives / Vol. 3 No. 8 (2013): August 2013 / Review Articles Intravenous ascorbic acid protocol for cancer patients: scientific rationale, pharmacology, and clinical experience Authors N. A. Mikirova Riordan Clinic, 3100 N Hillside, Wichita, KS J. J. Casciari Riordan Clinic, 3100 N Hillside, Wichita, KS R. E. Hunninghake Riordan Clinic, 3100 N Hillside, Wichita, KS N. H. Riordan Riordan Clinic, 3100 N Hillside, Wichita, KS DOI: https://doi.org/10.31989/ffhd.v3i8.43 Abstract Background: Ascorbic acid (vitamin C, ascorbate) has been shown to protect cells against various types of oxidant injury at physiologically relevant concentrations. Cancer patients are often deficient in vitamin C, and require large doses to replenish depleted stores.	cache/ffhd-43.htm	txt/ffhd-43.txt